X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

Translational Neurodegeneration

期刊標題檢索 TRANSL NEURODEG 最新評論: 20220701 Submit 20220704: Reviewers assigned 20220714: Under r... (2022-08-25)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[Translational Neurodegeneration]您好,您是該頁面的第 25920 位訪客。

期刊簡介
期刊名稱Translational Neurodegeneration Translational Neurodegeneration
LetPub Score
7.5
50 ratings
Rate

Reputation
8.4

Influence
6.4

Speed
9.7

期刊簡稱TRANSL NEURODEGENER
ISSN2047-9158
h-index28
CiteScore
CiteScoreSJRSNIPCiteScore Rank
19.503.3712.374
Subject fieldQuartilesRankPercentile
Category: Neuroscience
Subcategory: Cognitive Neuroscience
Q12 / 115
Category: Neuroscience
Subcategory: Neurology (clinical)
Q110 / 400
Category: Neuroscience
Subcategory: Cellular and Molecular Neuroscience
Q15 / 97

自引率 (2023-2024)0.90%自引率趨勢
掲載範囲
Translational Neurodegeneration is an open access, peer-reviewed journal that covers research, therapeutics and education for all aspects of neurodegenerative diseases. By offering a high-visibility forum for new insights and discussions, Translational Neurodegeneration creates a novel interface between the fields of basic, translational, and clinical research. It includes Parkinson's disease and movement disorders, Alzheimer's disease and other dementias, motor neuron disease and other neurodegenerative diseases.
官方網站https://www.springer.com/journal/40035
在線稿件提交https://www.editorialmanager.com/TNEU
開放訪問Yes
出版商BioMed Central
主題領域Neuroscience
出版國/地區United Kingdom
發行頻率
創刊年2012
每年文章數47每年文章數趨勢
黃金OA百分比100.00%
OA Related Info
APC: Yes( EUR2490; USD2890; GBP2090; )
APC waiver:Check Notes
Other charges: No
Keywords: neurodegenerative diseases、dementia、motor neurone disease、parkinson's disease、alzheimer's disease
Useful LinksAims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
NEUROSCIENCESSCIEQ113/310
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=2047-9158%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: 10 Weeks
競爭力 *來自作者的數據:
參考鏈接
相關期刊 【Translational Neurodegeneration】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    Current Opinion in Behavioral SciencesH-index: 0

    CiteScore: 10.90
    學科內最受檢索的期刊 頁面查看次數
    Current Opinion in Behavioral Sciences8186
  •  

    Translational Neurodegeneration Translational Neurodegeneration
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [Translational Neurodegeneration] 的評論撰寫評論
作者: He Yongtao


領域: 医学
審稿時間: 2.0 month(s)
結果: 拒稿


撰寫評論

2022-08-25 14:26:19 評論於
20220701 Submit
20220704: Reviewers assigned
20220714: Under review
20220812: Reviews completed
20220818: Editor assigned
20220820: Reject
20220823: Argue
20220825: Argue failed
(0) 讚! | He Yongtao

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 17:20:45 評論於
2 weeks to 3 months
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 15:54:36 評論於
Please translate the following paragraph into English and Japanese, using Google Translate
(0) 讚! | 维尔娜菲茨杰拉德

作者: 北国博达


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-28 09:37:03 評論於
How long does it typically take for a journal to review a manuscript?
(0) 讚! | 北国博达

作者: 上清雨真


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-26 23:00:11 評論於
I received a letter from the journal, but I can't understand it. What should I do?
(0) 讚! | 上清雨真

作者: Lena Rob


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-08-23 18:54:29 評論於
The magazine published by Ruijin Hospital, suspected to have low-level deputy editors. There was an AD genomic data research article with relatively good methodology and innovation. Following the trend of "writing papers on the motherland's soil" in 2020, and seeing similar imaging data research articles published in this magazine, I submitted to this 5-point magazine. After being assigned an editor for a week, I received a rejection email signed by Chen Shengdi, without any reasons given. I then transferred to the 6-point British magazine, Alzheimer's Research & Therapy, which was quickly reviewed, and after 2 weeks, it was accepted with minor revisions. After careful examination of the articles published in Translational Neurodegeneration in recent years, it seems that most are review articles by well-known researchers and articles from connections, which suggest submitting to journals with more competent deputy editors, such as Acta Neuropathologica Communications. There are many good domestic magazines, but this one is really lacking, haha
(0) 讚! | Lena Rob

作者: Libertad


領域: 生物
審稿時間: 1.0 month(s)
結果: 修改後接受


撰寫評論

2020-02-12 05:58:29 評論於
A new journal. It is very good, and the impact factor for the first year included is close to 6. The IF is expected to continue rising in the future, and the review speed is also very fast.

(2) 讚! | Libertad

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [Translational Neurodegeneration] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*